Cafepharma Today

June 23 2025 - Illumina bets on proteomics with $425m SomaLogic purchase
Illumina bets on proteomics with $425m SomaLogic purchase
Acting CDER head becomes latest in string of FDA leaders to leave agency
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
Roche's Hemlibra follow-up set for phase 3 in hemophilia A
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wednesday, December 17, 2014 - 8:13am
tags:
MannKind, Alexion, Akorn, Acorda Therapeutics
UCB Cancels Sale of Generic-Drug Unit to Buyout Firms
Bloomberg
Wednesday, December 17, 2014 - 8:04am
tags:
UCB Pharmaceuticals, M&A, generics
Amgen: Assessing The Split Up Value
Seeking Alpha
Tuesday, December 16, 2014 - 11:50pm
tags:
Amgen
FDA warns Pfizer antipsychotic linked to serious allergic reaction
In-Pharma Technologist
Tuesday, December 16, 2014 - 11:47pm
tags:
Geodon, Pfizer, antipsychotic, FDA, warnings
2 Large Blood Testing Companies Stand To Be Disrupted
Seeking Alpha
Tuesday, December 16, 2014 - 11:45pm
tags:
diagnostics, Quest Diagnostics, Laboratory Corporation of America
U.S. Patent Office Revises Guidelines After Drugmakers Complain
WSJ Pharmalot
Tuesday, December 16, 2014 - 7:48pm
tags:
US Patent Office, Myriad Genetics
FDA Approves INTERCEPT Blood System for Plasma
Yahoo
Tuesday, December 16, 2014 - 7:47pm
tags:
FDA, Cerus, Intercept Blood System for Plasma
FDA Allows InVivo Therapeutics To Expedite Enrollment For Spinal Injury Device
Yahoo/Zacks.com
Tuesday, December 16, 2014 - 7:45pm
tags:
FDA, Invivo Therapeutics, Neural-Spina Scaffolding, devices, spinal injury
Auspex Pharma's movement disorder drug succeeds late-stage trial
Yahoo/Reuters
Tuesday, December 16, 2014 - 7:43pm
tags:
Auspex Pharmaceuticals, chorea, Huntington's disease, SD-809
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs
TheStreet.com
Tuesday, December 16, 2014 - 12:06pm
tags:
biotech, Vertex Pharmaceuticals, Myriad Genetics, Dendreon, Celgene, Regeneron
FDA Ruling Blocking Celebrex Generics Reversed in Win For Mylan
Bloomberg
Tuesday, December 16, 2014 - 11:55am
tags:
FDA, Celebrex, Pfizer, Mylan Labs, generics, Lupin, Watson Laboratories
Novogen Shares Skyrocket 120% Following Melanoma Drug News
Yahoo/Benzinga
Tuesday, December 16, 2014 - 11:38am
tags:
Novogen, melanoma, TRXE-009
Activis to Replace Most Allergan Executives After Deal
Bloomberg
Tuesday, December 16, 2014 - 10:20am
tags:
Activis, Allergan, executives, M&A
Vivus Tries To Lead Obesity Space With Insurance Coverage
Seeking Alpha
Tuesday, December 16, 2014 - 8:18am
tags:
Vivus, obesity, insurance, Qsymia
Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact
Seeking Alpha
Tuesday, December 16, 2014 - 8:08am
tags:
Exelixis, cobemetinib, Roche, Genentech
Salix to fix inventory pile-up by end of 2015
Yahoo/Reuters
Tuesday, December 16, 2014 - 8:04am
tags:
Salix, inventory
Google Ventures Shifts Focus to Healthcare
WSJ Online
Tuesday, December 16, 2014 - 8:03am
tags:
Google Ventures
Judge blocking switch of patented Alzheimer's drugs until July; manufacturer to appeal
Yahoo/AP
Tuesday, December 16, 2014 - 8:02am
tags:
Alzheimer's disease, Namenda, Actavis
Galapagos loses partner on inflammatory bowel drug
Yahoo/Reuters
Tuesday, December 16, 2014 - 7:59am
tags:
Galapagos, inflammatory bowel disease, Janssen, ulcerative colitis, GLPG1205
Novartis quarterbacks a $34M round for Huntington's startup Annexon
Fierce Biotech
Monday, December 15, 2014 - 9:27pm
tags:
Novartis, Huntington's disease, Annexon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.